Guy’s Cancer, one of the leading cancer treatment and research centres in the UK, has entered into a collaboration with Careology, providers of the market leading digital cancer care platform.
The first-of-its-kind collaboration will see two leading organisations co-develop innovative new capabilities within Careology’s digital platform to help address major challenges in cancer care and improve outcomes and experiences for cancer patients. The five-year agreement will advance innovation in digital cancer care that helps to build capacity, drive efficiencies and improve patient experience at Guy’s and St Thomas’ NHS Foundation Trust. This new technology will also be available to the NHS nationwide and healthcare providers globally.
Dr Majid Kazmi, Director of Innovation for Cancer and Surgery and Deputy Medical Director, Guy’s and St Thomas’ NHS Foundation Trust said:
“I have been a passionate advocate for the adoption of patient centred, user-friendly digital technology to support cancer services. Digital technology has the potential to help patients and carers to be better informed and supported as well as giving healthcare workers the relevant information that allows them to provide a more responsive service and frees up time to care. We have been impressed with the approach taken by Careology and the strides they have already made to build an innovative and accessible solution. We are excited to be working together to build the world’s leading digital cancer care platform”.
Through Careology’s technology, the Trust can further support people and their families dealing with cancer by giving them access to crucial tools via its app and online, which they can use at home while being seamlessly connected to their care team.
Careology’s digital cancer care platform helps healthcare professionals to manage treatment for people living with cancer by providing remote insights and data which have never been available before. The collaboration will focus on enhancing and extending tools which will digitalise elements of the cancer pathway; improving early visibility of issues, reducing clinical administration, driving greater operational efficiencies and improving patient safety.
Careology allows patients to keep information about their treatment in one place, such as logging symptoms and side effects, managing their medicines and recording any issues. This gives clinicians a view of how patients are reacting to treatment between appointments, enabling them to care for patients more proactively and with better insight.
Additionally, through Careology’s partnership with Macmillan Cancer Support, patients at the trust will be able to access trusted and personalised information within the app to enable them to learn more about their condition and treatment.
The Trust will initially use the Careology platform with a particular cancer speciality to evaluate the impact of this technology including groups of cancer patients traditionally excluded from digital technology.
Paul Landau, Founder and CEO of Careology said:
“There’s a huge opportunity for digital to transform the delivery of traditional cancer care and we are incredibly excited about this collaboration as we pave the way for how digital is adopted in the sector. We are creating important technology that provides enhanced support for the patient as well as improved clinical insight, data and operational enhancements. Our collaboration with the Trust will allow us to accelerate the development and uptake of this vital new category with a world-class partner to help transform traditional cancer care through scalable technology so more people receive the best possible care.”
Dr Kazmi is also joining Careology’s board on behalf of Guy’s and St Thomas’ to ensure the two organisations have greater collaboration and insight.
------
About Careology
Careology is building the world’s leading digital cancer care platform. By equipping and seamlessly connecting patients, caregivers and healthcare teams in a complex pathway, our mission is to use technology to transform traditional cancer care and change everyone’s cancer story for the better. Today the platform allows patients to manage and navigate all aspects of treatment from their device, while leveraging critical data on symptoms, medications, side effects and more, to deliver insight and analysis to clinical teams through a ‘virtual ward’. By increasing the potential for patients to self-serve, improving workflows, making 24/7 monitoring possible and putting a unique data set to work, we are helping to relieve pressure on health systems, while reducing costs, improving patient and clinician experience, and optimising health outcomes.
About Guy’s and St Thomas’ NHS Foundation Trust
Guy's and St Thomas' provides 2.5 million patient contacts in acute and specialist hospital services and community services every year. The Trust includes Guy’s Hospital, St Thomas’ Hospital, Evelina London Children’s Hospital, Royal Brompton Hospital, Harefield Hospital, and adult and children’s community services in Lambeth and Southwark.
As one of the biggest NHS trusts in the UK, with an annual turnover of £2.6 billion, we employ around 23,500 staff.
Guy’s and St Thomas’ is part of King’s Health Partners Academic Health Sciences Centre (AHSC), a collaboration between King’s College London, and Guy’s and St Thomas’, King’s College Hospital and South London and Maudsley NHS Foundation Trusts.
